atepeq/tico19 huggingface dataset:
Around 10 March 2020, Emergent Biosolutions announced that it had teamed with Novavax Inc.
ኣብ ከባቢ 10 ማርች 2020፣ Emergent Biosolutions ምስ Novavax Inc ብሓባር ምስራሕ ምጅማሩ ኣብሲሩ።
in the development and manufacture of a vaccine.
ኣብ ምምዕባልን ምፍራይን ክታበት።
The partners further announced plans for preclinical testing and a Phase I clinical trial by July 2020.
እቶም መሻርኽቲ ናይ ቅድሚ ክሊኒካዊ ምርመራን ደረጃ I ክሊኒካዊ ፈተነን ኣብ ጁላይ 2020 ንምክያድ ትልሚ ከምዘለዎም ኣፍሊጦም።
On 12 March 2020, India's Health Ministry announced they are working with 11 isolates, and that even on a fast track it would take at least around one-and-a-half to two years to develop a vaccine.
ኣብ ማርች 12, 2020 ናይ ህንዲ ናይ ጥዕና ሚኒስቴር ምስ 11 ዝተነጸሉ ሰባት እንዳሰርሑ ምዃኖም ኣፍሊጡ ፣ ነቲ መድሓኒት ንምስራሕ በቲ ዝቐልጠፈ ኣሰራርሓ እውን እንተኾነ ብንኡሱ ካብ ሓደ ዓመትን ፈረቓን ክሳብ ክልተ ዓመት ከምዝወስድ ኣፍሊጡ።
On 12 March 2020, Medicago, a biotechnology company in Quebec City, Quebec, reported development of a coronavirus-like particle under partial funding from the Canadian Institutes for Health Research.
ኣብ ማርች 12፣ 2020፣ ኣብ ከተማ ኩዩቤክ ዝርከብ መዲካጎ ዝተብሃለ ትካል ኣብ ትሕቲ ናይ ካናዳ ናይ ጥዕና ምርምር ትካል ዝግበር ውሱን ናይ ገንዘብ ሓገዝ ኮይኑ ኮሮና ቫይረስ መሳሊ ባእታ ኣብ ምምዕባል ክምዝርከብ ፀብፃብ ኣቕሪቡ።
The vaccine candidate is in laboratory research, with human testing planned for July or August 2020.
እዚ ናይ ክትባት ሕጹይ ኣብ ናይ ቤትፈተነ መጽናዕቲ ይርከብ፣ ኣብ ሰብ ምፍታን ድማ ኣብ ጁላይ ወይ ኦገስት 2020 ክካየድ ትልሚ ተታሒዝዎ ኣሎ።
Earlier that week, The Guardian reported that the US President Donald Trump had offered CureVac "'large sums of money' for exclusive access to a Covid-19 vaccine", against which the German government protested.
ኣቐዲሙ ኣብ’ቲ ሰሙን፡ ናይ US ፕሬዝደንት ዶናልድ ትራምፕ ን CureVac ፡ ነቲ መንግስቲ ጀርመን ዝተቓወሞ ንምርካብ ክታበት “Covid-19 ዝውዕል ‘ብዙሕ ገንዘብ’ ኣቕሪቡ“ ክብል ዘ-ጋርዲያን ሓቢሩ።
On 17 March 2020, American pharmaceutical company Pfizer announced a partnership with German company BioNTech to jointly develop a mRNA-based vaccine.
ኣብ ማርች 17, 2020 ናይ ኣሜሪካ ናይ መድሓኒት ኩባንያ ፊዘር ምስ ናይ ጀርመን ኩባንያ ባዮኤንቴክ ብሓደ ናይ mRNA-based ክትባት ንምስራሕ ክምዝተውዓዓሉ ኣፍሊጡ።
mRNA-based vaccine candidate BNT162, currently in pre-clinical testing with clinical trials expected to begin in April 2020.
ኣብ mRNA ዝተመርኮሰ ክትባት ሕፁይ ዝኾነ BNT162 ኣብ ፕሪክሊኒካል ምርምር ዝርከብ እንትኾን፡ ቀፃሊ ናይ ክሊኒካል ፈተነታት ኣብ ሚያዝያ 2020 ክጅመር ከምዝኾነ ተሓቢሩ።
In Italy on 17 March 2020, Takis Biotech, an Italian biotech company announced they will have pre-clinical testing results in April 2020 and their final vaccine candidate could begin human testing by fall.
ኣብ ጣልያን ኣብ ማርች 17፣ 2020 ታኪስ ባዮቴክዝበሃል ናይ ጣልያን ትካል ኣብ ኣፕሪል፣2020 ናይ ክሊኒካዊ ውፂኢታት ብምርካብ እቲ ናይ መጨረሻ ኣብ ወዲ ሰብ ዝግበር ፈተነ ድማ ካብ መስከርም ኣቢሉ ክምዝጅምር ሓቢሮም ።
In France on 19 March 2020, the Coalition for Epidemic Preparedness Innovations (CEPI) announced a US$4.9 million investment in a COVID-19 vaccine research consortium involving the Institut Pasteur, Themis Bioscience (Vienna, Austria), and the University of Pittsburgh, bringing CEPI's total investment in COVID-19 vaccine development to US$29 million.
ማርች 19 2020 ኣብ ፈረንሳይ ናይ ኤፒደሚክ ኢኖቬሽን ሕብረት (CEPI) ናይ US$4.9 ሚሊዮን ኣብ ናይ COVID-19 ክትባት መፅናዕቲ ኢንቨስትመንት ከምዝገበረ ሓቢሩ። ካብ እዚ ብተወሳኺ ድማ ንኢኒስቲቱት ፓስተር፣ ቴሚስ ባዮሳይንስ (ቪዬና፣ኣዉስትሪያ) ከምኡ’ዉን ዩኒቨርስቲ ፒትስበርግ ብምስታፍ ጠቕላላ ንCOVID-19 ክትባት ምዕባለ ዝዉዕል ናይ CEPI ኢንቨስትመንት ናብ US$29 ሚልዮን ክዓቢ ክኢሉ።
CEPI's other investment partners for COVID-19 vaccine development are Moderna, Curevac, Inovio, Novavax, the University of Hong Kong, the University of Oxford, and the University of Queensland.
ናይ CEPI ናይ ኢንቨስትመንት ምሻርኽቲ ንCOVID-19 ዝኸዉን ክትባት ንምምዕባል ዝሳተፉ፡ ሞደርና፣ ኩሬቫክ፣ ኢኖቭዮ፣ ኖቫቫክስ፣ ዩኒቨርስቲ ሆንግ ኮንግ፣ ዩኒቨርስቲ ኦክስፎርድ ከምኡዉን ዩኒቨርስቲ ክዊንስላንድ ኣለዉ።
On 20 March 2020, Russian health officials announced that scientists have begun animal testing of six different vaccine candidates.
ኣብ 20 ማርች 2020፣ ናይ ሩስያ ጥዕና ኦፊሻላት ሳይቲስትታት ናይ ሽድሽተ ዝተፈላለዩ ናይ ክትባት ሕጹያት ኣብ እንስሳት ምፍታን ምጅማሮም ገሊጾም።
Imperial College London researchers announced on 20 March 2020 that they are developing a self-amplifying RNA vaccine for COVID-19.
ኣብ ማርች 20፣2020 ናይ ሎንደን ኢምፐሪያል ኮሌጅ ተመራመርቲ ን COVID-19 ዝኾን ዓርሱ ዘጋውሕ ናይ RNA ክትባት ኣብ ምምዕባል ክምዝርከቡ ሓቢሮም።
The vaccine candidate was developed within 14 days of receiving the sequence from China.
እቲ ተወዳዳሪ ክታበት ኣብ ውሽጢ 14 መዓልታት ምቕባል ኣሰራርዓ ሕነተ-ሰረት ካብ ቻይና ማዕቢሉ።
In late March, the Canadian government announced C$275 million in funding for 96 research projects on medical countermeasures against COVID-19, including numerous vaccine candidates at Canadian companies and universities, such as the Medicago and University of Saskatchewan initiatives.
ኣብ መወዳእታ ማርች፡ መንግስቲ ካናዳ ከም መዲካጎ ን ተበግሶ ዩኒቨርሲቲ ሳስካቸዋንን ዝመሰሉ ናይ ካናዳ ዩኒቨርሲቲታትን ትካላትን ከም ሕክምናዊ ሰረ-ስጉምቲ ኣንጻር COVID-19 ኣብ ዘቕረብዎም ብዙሓት ሕጹያት ክታበታት ዝትግበሩ 96 ናይ መጽናዕቲ ውጥናት ንምምዋል 275 ሚሊዮን ዶላር ካናዳ ክህብ ምዃኑ ኣዊጁ።
Around the same time, the Canadian government announced C$192 million specifically for developing a COVID-19 vaccine, with plans to establish a national "vaccine bank" of several new vaccines that could be used if another coronavirus outbreak occurs.
ኣብ ተመሳሳሊ ግዜ መንግስቲ ካናዳ ንምምዕባል ናይ COVID-19 ክታበት ዝውዕል 192 ሚልዮን ዶላር ካናዳ ከምኡ’ውን ካልእ ለበዳ ኮሮና ቫይረስ ምስ ዘጋጥም ዝጠቅም ብዙሓት ሕደስቲ ክታበታት ዝህልዎ “ናይ ክታበት ባንክ” ንምምዕባል መደባት ኣፍሊጡ፡፡
On 2 April 2020, researchers at the University of Pittsburgh School of Medicine reported on testing of PittCoVacc, a possible COVID-19 vaccine in mice, stating that "MNA delivered SARS-CoV-2 S1 subunit vaccines elicited potent antigen-specific antibody responses [in the mice] that were evident beginning 2 weeks after immunization."
ኤፕሪል 2 2020 ናይ ፒትስበርግ ዩኒቨርስቲ ቤት-ትምህርቲ ሕክምና ተመራመርቲ ናይ PittCoVacc ዝበሃል ናይ COVID-19 ክትባት ኣብ ኣናፁ ምርምር ‘’ናይ SARS-CoV-2 S1 ሳብዩኒት ክትባት ጠንካራ ናይ ኣንቲጅን-ስፔስፊክ ኣንቲቦዲ መልሲ [ኣብ ኣናፁ] ከምዘምፀ MNA ኣፍሊጡ። እዚ ድማ ኢምዩናይዜሽን ምስተፈጥረ ድሕሪ 2 ሰሙን ይፍጠር።’’
In Canada on 16 April 2020, the University of Waterloo School of Pharmacy announced design of a DNA-based vaccine candidate as a possible nasal spray.
ኤፕሪል 16 2020 ኣብ ካናዳ ውሽጢ ዝርከብ ዋተርሉ ዩኒቨርሲቲ ቤት-ትምህርቲ ፋርማሲ DNA ዝመሰረቱ ናይ ክታበት ብኣፍንጫ ዝንጸግ ሕጹይ ይምስርት ከምዘሎ ሓቢሩ።
Using bacteriophages, the DNA will be designed to replicate inside human bacteria to produce harmless virus-like particles, which may stimulate the immune system to produce antibodies against the SARS-CoV-2 virus.
ባክቴሪዮፌጅስ ኣብ ጥቕሚ ብምዋዓል፣ እቲ DNA ኣብ ውሽጢ ናይ ወዲስብ ኣብ ዝርከብ ባክቴሪያ ውሽጢ ብምርባሕ ጉዳኣት ዘይብሉ ቫይረስ መስል ባእታታት ብምፍራይ እቲ ናይ ሰብነትና ሕማምም ተከላኻሊ ኣናፃር ሳርስ ኮሮና ቫይረስ (SARS-CoV-2) ናይ ባዕዳዊ ነገራት መከለኻሊ የፍሪ።
In March 2020, the US government, industry, and three universities pooled resources to access supercomputers from IBM, combined with cloud computing resources from Hewlett Packard Enterprise, Amazon, Microsoft, and Google.
ኣብ ማርች 2020፣ ናይ US መንግስቲ፣ ኢንዳስትሪን ሰለስተ ዩኒቨርስቲታትን ናይ IBM ሱፐር ኮምፒዩተራት ፣ ምስ ናይ ክላውድ ኮምፒቲንግ ሓገዛት ናይ Hewlett Packard Enterprise፣ Amazon፣ Microsoft፣ ከምኡውን Google ብምትሕብባር ንምጥቃም ፍልፍላት ሃብቲ ኣኪቦም እዮም።
Some vaccines have heterologous effects, also called non-specific effects.
ሓድሓደ ክትባታት ውሱናት ዘይኮኑ ወይድማ ዝበሃሉ ሳዕቤናት ኣለዎም።
That means they can have benefits beyond the disease they prevent.
እዚ ማለት ድማ ካብቲ ዝከላኸልዎ ሕማም ንላዕሊ ጥቕሚ ክረኽቡ ይኽእሉ እዮም ማለት እዩ።
A further randomized trial in Australia is seeking to enrol 4,170 healthcare workers.
ኣብ አውስትራሊያ ዝግበር ተወሳኺ ሃንደበታዊ ሙከራ 4,170 ናይ ጥዕና ሰራሕተኛታት እናጠለበ ይርከብ።
It is possible vaccines in development will not be safe or effective.
ኣብ ምምዕባል ዝርከቡ ክትባታት ውሕስነቶም ዝተሓለዉ ወይ ኣድማዕቲ ዘይክኾኑ ይኽእሉ እዮም።
Early research to assess vaccine efficacy using COVID-19-specific animal models, such as ACE2-transgenic mice, other laboratory animals, and non-human primates, indicate a need for biosafety-level 3 containment measures for handling live viruses, and international coordination to ensure standardized safety procedures.
ኣድማዕነት ክታበት ንምፍታሽ ኣብ ን COVID-19 ውሱናት ሞዴል እንስሳታት ዝተገብረ መጽናዕቲ፡ ከም ACE2-ስግረ-ጂናዊ ኣናጹ፡ ካልኦት ናይ ላብራቶሪ እንስሳታት፡ ከምኡ’ውን ኣብ ሰባት ዘይኮኑ መጥበውቲ ቫይረሳት ንምቁጽጻር ኣገዳስነት ናይ ደረጃ 3 ባዮ-ሴፍቲ ናይ ምሓዝ ስጉምትታት ከምኡ’ውን ደረጅኡ ዝሓለወ ናይ ድሕነት መስርሓት ንምውሓስ ኣህጉራዊ ምውህሃድ የመልክት።
Vaccines against SARS and MERS have been tested in non-human animal models.
ን SARS ከምኡ’ውን ንMERS ዝኸውን ክታበት ኣብ ደቂሰብ ዘይኮኑ ናይ እንስሳት ሞዴላት ይፍተኑ ጸኒሖሞ እዮም።
As of 2020, there is no cure or protective vaccine for SARS that has been shown to be both safe and effective in humans.
ኣብ 2020 SARS ድሕንነቱ ዝሓለወን ዉፅኢታዊ ዝኾነን መድሓኒት ወይድማ ተኻላኸሊ ክትባት የብሉን።
According to research papers published in 2005 and 2006, the identification and development of novel vaccines and medicines to treat SARS was a priority for governments and public health agencies around the world.There is also no proven vaccine against MERS.
ኣብ 2005 ን 2006 ን ብዝተሓተሙ ናይ መጽናዕቲ ወረቐታት መሰረት፣ ናይ እዚ SARS ሓድሽ ክትባት ወይ መድሓኒት ምምዕባል ናይ መንግስቲታትን ህዝባዊ ጥዕና ሓለዋን ቀዳምነት ዝህብዎ ነገር እዩ።ኣንጻር MERS እውን ዝተረጋገጸ ክትባት የለን።
When MERS became prevalent, it was believed that existing SARS research may provide a useful template for developing vaccines and therapeutics against a MERS-CoV infection.
MERS ብጣዕሚ ኣስፋሕፊሑ ኣብ ዝነበረሉ ግዘ ሕጂ ዘሎ ናይ SARS ምርምር ኣንጻር MERS-CoV ረኽሲ ክታበትን መድሓኒታትን ንምምዕባል ጠቓሚ ኣብነት ክህልዎ ከምዝኽእል እምነት ነይሩ እዩ።
As of March 2020, there was one (DNA based) MERS vaccine which completed phase I clinical trials in humans, and three others in progress, all of which are viral-vectored vaccines, two adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac), and one MVA-vectored (MVA-MERS-S).
ካብ ማርች 2020 ጀሚሩ፣ ሓደ ብርኪ I ኣብ ደቂ ሰባት ናይ ክሊኒካዊ ፈተነ ዝወደአን ፣ ካልኦት ሰለስተ ድማ ኣብ መሰርሕ ዝርከቡሉን፣ ኩሎም ድማ viral-vectored እቶም ክልተ ድማ adenoviral-vectored (ChAdOx1-MERS, BVRS-GamVac) ሓድ ድማ MVA-vectored (MVA-MERS-S) ዝኾነ (DNA ዝተድረኸ) ናይ MERS ክትባትት ነይሩ።
Social media posts have promoted a conspiracy theory claiming the virus behind COVID-19 was known and that a vaccine was already available.
ናይ ማሕበራዊ ሚድያ ፖስትታት እቲ ናይ ኮቪድ-19 ቫይረስ ይፍለጥ ከምዝነበረን ክትባት እውን ከምዘለዎን ዝገልጽ ስነ-ሓሳብ ኣቕሪቦም ኣለዉ።
The patents cited by various social media posts reference existing patents for genetic sequences and vaccines for other strains of coronavirus such as the SARS coronavirus.
እቶም ኣብ ማሕበራዊ ሚድያታት ዝርከቡ ናይ ዋንነት ሰርትፍኬታት ከም SARS ዝመሳሰሉ ናይ ካልኦት ኮሮና ቫይረስ ስትሬናት ጀነቲክ ሲኩዌንስን ክትባትን ዋንነት ሰርትፍኬታት እዮም።
b'Coronaviruses are a group of related viruses that cause diseases in mammals and birds.
ቢ’ኮሮና ቫይረሳት ዝመሳሰሉ ጉጅለ ቫይረሳት ኮይኖም ኣብ ኣዕዋፍን መጥበውትን ሕማማት ዘስዕቡ እዮም።
In humans, coronaviruses cause respiratory tract infections that can range from mild to lethal.
ኣብ ሰባት፣ ኮሮና ቫይረሳት ካብ ቀሊል ክሳብ ቀታሊ ክኸዱ ዝኽእሉ ናይ መተንፈሲ ኣካላት ረኽሲታት የ ስዕቡ እዮም።
Mild illnesses include some cases of the common cold (which has other possible causes, predominantly rhinoviruses), while more lethal varieties can cause SARS, MERS, and COVID-19.
ቅልል ዝበሉ ሕማማት ከም ሓድ-ሓደ ልሙድ ሰዓል የጠቓልሉ (ካልኦት ጠንቅታቱ ክኾኑ ዝኽእሉ ብቐንዱ ራይኖቫይረስ)፡ ዝያዳ ቀተልቲ ዝኾኑ ዘርኢታት SARS, MERS, and COVID-19 ከስዕቡ ይኽእሉ።
Symptoms in other species vary: in chickens, they cause an upper respiratory tract disease, while in cows and pigs they cause diarrhea.
ኣብ ካልኦት ዘርኣዩ ናይ ሕማም ምልክታት ኣብ መንጎ ዓሌታት እንስሳ ይፈላለዩ እዮም፥ ኣብ ደርሁ ዝለዓለ ናይ መተንፈሲ ኣካላት ሕማም የስዕቡ፡ ኣብ ኣላሕምን ኣብ ሓሰማን ድማ ተቕማጥ የስዕቡ።
There are yet to be vaccines or antiviral drugs to prevent or treat human coronavirus infections.
ካብ ረኽሲ ኮሮና ቫይረስ ዘሓውዩን ዝከላኸሉ ክትባታትን ጸረ-ቫይረስ መድሓኒታት ገና ብሕዚ እዮም ክስርሑ።
Coronaviruses constitute the subfamily Orthocoronavirinae, in the family Coronaviridae, order Nidovirales, and realm Riboviria.
ኮረና ቫይረስ ኦርቶ ኮረና ቫይራይን ዝተብሃሉ ክፋላት ዓሌት ዘጠቓለለ እዩ፣ ኣብቲ ዓሌት ድማ ኮሮናቪሪዴ፣ ኦርደር ኒዶቪራልስን ረልም ሪቦቪሪያ ዝበሃሉን ዘጠቓለለ እዩ።
They are enveloped viruses with a positive-sense single-stranded RNA genome and a nucleocapsid of helical symmetry.
እዚኦም ኤንቨሎፕድ ቫይረሳት እንትኾኑ ፖዘቲቭ-ሰንስ ሲንግል-ስትራንድድ RNA ጀኖም ኮይኖም ናይ ሄሊካል ሲመትሪ ኑክሊዮካስፒድ ዘለዎም እዮም።
The genome size of coronaviruses ranges from approximately 26 to 32 kilobases, one of the largest among RNA viruses.
ናይ እቲ ኮሮናቫይረስ ናይ ጄኖም መጠን ካብ 26 ክሳብ 32 ኪሎቤዝ ይኸውን፣ ሓደ ካብቶም RNA ቫይረሳት ዓበዪ ዝበሃል እዩ።
They have characteristic club-shaped spikes that project from their surface, which in electron micrographs create an image reminiscent of the solar corona from which their name derives.
ክለብ ቅርፂ ዝመስሉ ኣንቴና ካብ እቲ ወለል ዝወፁ ይረኣዩ። እዚኦም ድማ ኣብ ኤለክትሮን ማይክሮግራፍ ንሶላር ኮሮና ዝመስል የርኢ፡ ሽሙ ድማ ካብ እዚ እዩ ተወሲዱ።
Coronaviruses were first discovered in the 1930s when an acute respiratory infection of domesticated chickens was shown to be caused by infectious bronchitis virus (IBV).
ኮሮና ቫይረሳት ንመጀመርታ ግዜ ኣብ 1930ታት ሃንደበታዊ ናይ ስርዓት ምስትንፋስ ኢንፌክሽን ኣብ ደራሁ ብተመሓላላፋይ ብሮንካይተስ ምምፃኡ ምስተፈለጠ እዩ ተረኺቡ።
In the 1940s, two more animal coronaviruses, mouse hepatitis virus (MHV) and transmissible gastroenteritis virus (TGEV), were isolated.Human coronaviruses were discovered in the 1960s.
ኣብ 1940ታት ናይ ኣንጭዋ ናይ ወይቦ ቫይረስን (TGEV) ተመሓላላፊ ናይ ነድሪ-ኣምዑት ቫይረስን ዝበሃሉ ክልተ ተወሰኽቲ ናይ እንስሳ ኮሮና ቫይረሳት ተለልዮም፡፡ ናይ ሰብ ኮሮና ቫይረሳት ኣብ 1960ታት ተፈሊጦም ።
The earliest ones studied were from human patients with the common cold, which were later named human coronavirus 229E and human coronavirus OC43.
እቶም ቀዲሞም ዝተጸንዑ ካብ ጉንፋዕ ዝሓመሙ ሰባት ኔሮም ።ጸኒሖም ድማ ሂዩማን ኮሮና ቫይረስ 229Eን ሂዩማን ኮሮና ቫይረስ OC43 ን ተባሂሎም ተሰምዮም ።
They were first imaged by Scottish virologist June Almeida at St. Thomas Hospital in London.
ብመጀመሪያ ብናይ ስኮትላንዳዊት ቪሮሎጂስት ጁን ኣልሜዳ እዮም ኣብ ሴይንት ቶማስ ሆስፒታል ኣብ ለንደን ተራእዮም።
Other human coronaviruses have since been identified, including SARS-CoV in 2003, HCoV NL63 in 2004, HKU1 in 2005, MERS-CoV in 2012, and SARS-CoV-2 in 2019.
ካብ ሽዒቱ ኣትሒዞም ካልኦት ናይ ሰባት ኮሮና ቫይረሳት ተፈልዮም ኔሮም፣ SARS-CoV ብ 2003፣ HCoV NL63 ብ 2004፣ HKU1 ብ 2005፣ MERS-CoV ብ 2012ን SARS-CoV-2 ብ 2019።
Most of these have involved serious respiratory tract infections.
መብዛሕትኦም እዚኦም ከቢድ ናይ ስርዓተ ምትንፋስ ረኽሲ ኣጋጢምዎም።
The name was first used in 1968 by an informal group of virologists in the journal Nature to designate the new family of viruses.
እቲ ሽም ንመጀመርታ ግዜ ስሩዕ ብዘይኮነ ናይ ቫይሮሎጂስታት ጉጅለ ኣብ ጆርናል ኔቸር ነቲ ሓድሽ ቫይረስ ንምግላፅ ኣብ 1968 እዩ ኣብ ጥቕሚ ውዒሉ።
The name refers to the characteristic appearance of virions (the infective form of the virus) by electron microscopy, which have a fringe of large, bulbous surface projections creating an image reminiscent of a crown or of a solar corona.
እቲ ሽም ነቲ ፍሉይ መልክዕ ናይ እቶም ቪሮንስ(እቶም ተላባዕቲ/ለኸፍቲ ዝኾኑ መልክዕ ናይ እቲ ቫይረስ) ዘንጸባርቕ ኮይኑ ኣብ ትሕቲ ኤሌክትሮን ማይክሮስኮፕ ዓበይቲ, ዝለዓለ ዓቐን ዘለዎም ጩራታት ልክዕ ከም ዘውዲ ጸሓ(ፎቶ-ቮልታዊ) ትዝ ዘብል ምስሊ ይርኣይ።
This morphology is created by the viral spike peplomers, which are proteins on the surface of the virus.
እዚ ሞርፎሎጂ ብናይቲ ቫይራል ስፓይክ ፖሊመራት ዝተፈጠረ እዩ፣ ኣብ እቲ ናይ ቫይረስ ደጋዊ ክፋል ፕሮቲናት እዮም ዘለዉ።
Coronaviruses are large pleomorphic spherical particles with bulbous surface projections.
ኮሮናቫይረሳት ዓበይቲ ፕሊዮሞርፊክ ስፌሪካል ንጥረ ነገራት ናይ ደጋዊ ጨንፈራት ዘለዎም እዮም።
The envelope of the virus in electron micrographs appears as a distinct pair of electron dense shells.The viral envelope consists of a lipid bilayer where the membrane (M), envelope (E) and spike (S) structural proteins are anchored.
ናይ እዚ ቫይረስ ሽፋን ኣብ ኤሌክትሮን ማይክሮግራፋት ከም ፍሉይ ጽዑቕ ናይ ኤሌክትሮን ጽምዲ ሽፋናት ኮይኑ ይረአ።እዚ ቫይራል ሽፋን ሊፒድ ባይለየር ኣለዎ ረቂቕ ሽፋን (M)፣ ሽፋን (E) ከምኡውን ስፓይካት (S) ቅርጺ ዘለዎም ፕሮቲናት ዝጣበቑሉ።
The lipid bilayer envelope, membrane proteins, and nucleocapsid protect the virus when it is outside the host cell.
ሊፒድ ባይለየር መሸፈኒ፣ ሽፋን ፕሮቲንን፣ ኒኩሎካፕሲድን ነቲ ቫይረስ ካብቲ ናይቲ ሰብ ዋሃዮ ወጻኢ እንተኾይኑ ይሕልውዎ።
Coronaviruses contain a positive-sense, single-stranded RNA genome.
ኮሮናቫይረስ ፖዘቲቭ-ሰንስ፣ ሲንግል ስትራንድድ RNA ጄኖም ይዉንን።
The genome size for coronaviruses ranges from 26.4 to 31.7 kilobases.
ናይ ኮሮና ቫይረስ ጄኖም መጠን ካብ 26.4 እስካብ 31.7 ኪሎቤዝ ይኸዉን።
The genome size is one of the largest among RNA viruses.
እዚ ናይ ጄኖም መጠን ካብቶም ናይ RNA ቫይረሳት እቲ ዝዓበየ እዩ።
The open reading frames 1a and 1b, which occupy the first two-thirds of the genome, encode the replicase/transcriptase polyprotein.
መጀመሪያ ክልተ ሲሶ ናይቲ ጄኖም ዝሕዙ ክፍቲ መንበብታት ፍሬም 1aን 1b እቲ ረፕሊኬዝ/ትራንስክሪፕቴዝ ፖሊ ፕሮቲን ኢንኮድ ይገብር።
The replicase/transcriptase polyprotein self cleaves to form nonstructural proteins.The later reading frames encode the four major structural proteins: spike, envelope, membrane, and nucleocapsid.
እዚ replicase/transcriptase polyprotein (ሪፕሊኬዝ/ትራንስክሪፕቴዝ ፖሊፕሮቲን) ቅርጺ ዘይብሎም ፕሮቲናት ንምፍጣር ዓርሱ ይቖራርጽ።እም ድሕሪኡ ዝወጹ ፍሬማት ኣርባዕተ ዋና ቅርጺ ዘለዎም ፕሮቲናት ኢንኮድ ይገብሩ: ስፓይክ፣ ሽፋን፣ ረቂቕ ሽፋንን ኒኩሎካፕሲድን።
Interspersed between these reading frames are the reading frames for the accessory proteins.
ኣብ ሞንጎ እዞም ንባብ ፍሬም ዝኣትዉ ናይ ተወሰኽቲ ፕሮቲናት ዝኾኑ ንባብ ፍሬም እዮም።
The number of accessory proteins and their function is unique depending on the specific coronavirus.
ናይ ኣከሰሰሪ ፕሮቲናተ ቁጽሪን ኣሰራርሕኦምን ከከም ኮሮናቫይረሱ ፍሉይ እዩ።
Infection begins when the viral spike (S) glycoprotein attaches to its complementary host cell receptor.
ረኽሲ ናይ ቫይረስ በሊሕ ብ ግላይኮፕሮቲን ዝተሰርሐ ጫፍ ምስ ናቱ ተዛማዲ ናይ ኣኣንጋዳይ ተቐባል ኣካል ዋህዮ ምስ ዝተሓሓዝ ይጅምር ።
After attachment, a protease of the host cell cleaves and activates the receptor-attached spike protein.
ድሕሪ ምትሕሓዝ፣ ናይቲ ሰብ ዋህዮ ፕሮቴዝ ምቑራጽ ይጅምር ንናይቲ ተቐባሊ-ተታሒዙ ዘሎ ፕሮቲን ስፓይክ እውን የነቓቕሕ።
Depending on the host cell protease available, cleavage and activation allows the virus to enter the host cell by endocytosis or direct fusion of the viral envelop with the host membrane.On entry into the host cell, the virus particle is uncoated, and its genome enters the cell cytoplasm.
ኣብ ናይ እቲ ሰብ ዋህዮ ፕሮቴዝ ተወሲኑ፣ ምቑራጽን ምንጣፍን እቲ ቫይረስ ናብ እቲ ሰብ ዋህዮ ኢንዶሳይቶሲስ ንክኣቱ ይገብሮ ወይ ድማ ናይ እቲ ቫይረስ ሽፋን ምስ ናይ እቲ ዋህዮ ረቂቕ ሸፋን ብቐጥታ ክተሓሓዝ ብምግባር ክኣቱ ይገብሮ።ናብ እቲ ዋህዮ ክኣቱ ከሎ እቲ ቫይረስ ሽፋኑ ኣውጺኡ እዩ፣ ጄኖሙ ሽዑ ናብ እቲ ዋህዮ ሳይቶፕላዝም ይኣቱ።
The host ribosome translates the initial overlapping open reading frame of the virus genome and forms a long polyprotein.
ናይ እቲ ተሸካሚ ራይቦዞም እቲ ናይ መጀመርታ ንፁር ምድርራብ ንባብ ፍሬም ናይ እቲ ቫይረስ ጄኖም ይትርጉም። ከምኡውን ነዊሕ ፖሊፕሮቲን ይምስርት።
The polyprotein has its own proteases which cleave the polyprotein into multiple nonstructural proteins.
እዚ ፖሊፕሮቲን ናይ ባዕሉ ፕሮቴዝ ኣለዎ ንፖሊፕሮቲናት ናብ ብዙሓት ቅርጺ ዘይብሎ ፕሮቲናት ዝቖራርጽ።
A number of the nonstructural proteins coalesce to form a multi-protein replicase-transcriptase complex (RTC).
ብዙሓት ቅርጺ ዝይብሎም ፕሮቲናት ብምስማር ብዙሕ ፕሮቲን ዘለዎ ረፕሊኬዝ-ትራንስክሪፕቴዝ (RTC) ይሰርሑ።
The main replicase-transcriptase protein is the RNA-dependent RNA polymerase (RdRp).
እቲ ዋና ረፕሊኬዝ-ትራንስሪፕቴዝ ፕሮቲን RNA-ዲፐንደንት RNA ፖሊመሬዝ (RdRp) እዩ።
It is directly involved in the replication and transcription of RNA from an RNA strand.
ምስ ናይ RNA ካብ ናይ RNA ስትራንድ ምርባሕን ትራንክሪፕሽንን ብቐጥታ ዝተተሓሓዘ እዩ።
The other nonstructural proteins in the complex assist in the replication and transcription process.
ኣብ ዝተሓላለኸ ውሽጢ ዘለዉ ካልኦት ትሕተ-ልምዓት ዝኾኑ ፕሮቲናት ኣብ ምብዛሕን ናይ ትራንስክሪፕሽን መስርሕ ይሕግዙ።
The exoribonuclease nonstructural protein, for instance, provides extra fidelity to replication by providing a proofreading function which the RNA-dependent RNA polymerase lacks.One of the main functions of the complex is to replicate the viral genome.
ንኣብነት ኤክዞራይቦኒዩክሌዝ ዘይመዋቕራዊ ፕሮቲን ንምርባሕ ናይ RNA-መሰረት ዝገበረ RNA ፖሊመሬዝ ሕፅረት ናይምፅራይ ተግባር ብምብርካት ተወሳኺ ተኣማንነት የበርክት። እዚ ዉሁድ ካብ እቶም ዝግብሮም እቲ ሓደ ቫይራል ጄኖም ምርባሕ እዩ።
RdRp directly mediates the synthesis of negative-sense genomic RNA from the positive-sense genomic RNA.
RdRp ብቐጥታ ን ናይ ኣሉታ ሸነኽ ጂኖማዊ ካብ RNA ኣዎንታ ሸነኽ ጂኖማዊ RNA ክስራሕ ከም መንጎኛ ይሰርሕ።
This is followed by the replication of positive-sense genomic RNA from the negative-sense genomic RNA.
እዚ ድማ ብ ኣወንታዊ-ናይ ስምዒት ጄኖሚክ RNA ካብ ኣሉታዊ-ስምዒት ጄኖሚክ RNA ምብዛሕ ዝመጸ እዩ።.
The other important function of the complex is to transcribe the viral genome.
እቲ ካልእ ኣገዳሲ ናይ እቲ ዉሑድ ስራሕ ቫይራል ጄኖም ትራንስክራይብ ምግባር እዩ።
RdRp directly mediates the synthesis of negative-sense subgenomic RNA molecules from the positive-sense genomic RNA.
RdRpብቐጥታ ንምምስራሕ ቅዳሕ ሕነተ-ሰረት ሞለክዩላዊ RNAካብ ቀንዲ ሕነተ-ሰረት ሞለክዩላዊ RNA የሳሲ።
This is followed by the transcription of these negative-sense subgenomic RNA molecules to their corresponding positive-sense mRNAs.
ናይ ኣሉታዊ-ሰንስ ሳብጄኖሚክ RNA ሞለኪይዩል ምስ ተዛማዲ ኣወንታዊ-ሰንስ mRNAs ዝግበር ትራንስክሪፕሽን ድማ ቀፂሉ ይመፅእ።
The replicated positive-sense genomic RNA becomes the genome of the progeny viruses.
እቲ ዝተራብሐ ፖዘቲቨ-ሰንስ ጄኖሚክ RNA ናይ እቲ ሓድሽ ዝተወልደ ቫይረስ ጄኖም ኮይኑ ዘገልግል እዩ።
The mRNAs are gene transcripts of the last third of the virus genome after the initial overlapping reading frame.
mRNAs ድሕሪ እቲ ናይ ፈላማይ ናይ ንባብ ምድርራብ ፍሬም ዝመፅእ ናይ መወዳእታ ሲሶ ናይ ቫይረስ ጄኖም ጂን ትራንስክሪፕት እዩ።
These mRNAs are translated by the host's ribosomes into the structural proteins and a number of accessory proteins.
እዞም mRNAታት በቲ ናይ እቲ ሰብ ራይቦዞማት ናብ ቅርጺ ዘለዎም ፕሮቲናትን ብዙሓት ሓገዝቲ ፕሮቲናትን ይትርጎሙ።
RNA translation occurs inside the endoplasmic reticulum.
ናይ RNA ምትርጓም ኣብ ውሽጢ ኢንዶፕላዝሚክ ረቲኩለም ይካየድ።
The viral structural proteins S, E, and M move along the secretory pathway into the Golgi intermediate compartment.
ናይ እቲ ቫይረስ መዋቕር ፕሮቲን S፣ Eን Mን ብሴክሬቶሪ መንገዲ ናብ ማእኸላይ ክፍሊ ጎልጂ ይኣቱ።
There, the M proteins direct most protein-protein interactions required for assembly of viruses following its binding to the nucleocapsid.
ድሕሪ ምትእስሳር፣ ናይ እቶም ቫይረሳት ንንምትእኽኻብ ዘድልዩ ኣብዝሓ ናይ ፕሮቲን-ፕሮቲን ርክባት ብM ፕሮቲናት ናብ ኒኩልዮካፕሲድ ይስደዱ።
Progeny viruses are then released from the host cell by exocytosis through secretory vesicles.
ሓድሽ ዝተወለዱ ቫይረሳት ካብ ናይ እቲ ተሸካማይ ዋህዮ ብሴክረቶሪ ቬስክል ኣቢሎም ኤክሶሳይቶሲስ ብምጥቃም ይልቀቑ።
The interaction of the coronavirus spike protein with its complement host cell receptor is central in determining the tissue tropism, infectivity, and species range of the virus.
ኣብ ሞንጎ ናይ ኮሮና ቫይረስ ስፓይክ ፕሮቲንን ናይ እቲ ተሸካማይ ዋህዮ ተቐባሊን ዝፍጠር ርክብ ንቲሹ ትሮፒዝም፣ ሰብ ናይ ምጥቃዕ ዓቕሙን ናይ እቲ ቫይረስ ዘርኢ ርሕቐትን ንምዉሳን ጠቓሚ እዩ።
The SARS coronavirus, for example, infects human cells by attaching to the angiotensin-converting enzyme 2 (ACE2) receptor.
ንኣብነት SARS ኮርና ቫይረስ፣ኣብ ኣንጂዮተነሲን ቀያሪ ኢንዛይም 2 ብምጥባቕ ናይ (ACE2) ተቐባሊ ብ ምቕያር ኣብ ናይ ደቂ-ሰባት መትኒታት ረኽሲ ይፈጥሩ።
The scientific name for coronavirus is Orthocoronavirinae or Coronavirinae.
ናይ ኮሮናቫይረስ ሳይንሳዊ ሽሙ ኦርቶኮሮናቫይራይን ወይ ኮሮናቫይራይን እዩ።
Coronaviruses belong to the family of Coronaviridae, order Nidovirales, and realm Riboviria.
ኮሮና ቫይረሳት ካብ ኮሮናቫይሪዴይ ዝበሃል ስድራ፣ካብ ኒዶቫይሬልስ ኦርደር ከምኡውን ካብ ራይቦቫይራ ሬልም ዝወፁ እዮም።
Genus Betacoronavirus; type species: Murine coronavirus
ገኑስ ቤታ ኮሮናቫይረስ፣ ዓይነት ዘርኢ፡ ሙሪን ኮሮናቫይረስ
Species: Betacoronavirus 1 (Bovine Coronavirus, Human coronavirus OC43), Human coronavirus HKU1, Murine coronavirus, Pipistrellus bat coronavirus HKU5, Rousettus bat coronavirus HKU9, Severe acute respiratory syndrome-related coronavirus (SARS-CoV, SARS-CoV-2), Tylonycteris bat coronavirus HKU4, Middle East respiratory syndrome-related coronavirus, Hedgehog coronavirus 1 (EriCoV)
ዘርእታት፡ ቤታኮሮናቫይረስ 1 (ቦቫይን ኮሮርናቫይረስ፣ሂዩማን ኮሮርናቫይረስ OC43)፣ሂዩማን ኮሮናቫይረስ HKU1፣ሚዩሪን ኮሮናቫይረስ፣ፒፒስትሬለስ ባት ኮሮናቫይረስ HKU5፣ሮዜተስ ባት ኮሮናቫይረስ HKU9 ከቢድ ህፁፅ ናይ መተንፈሲ ኣካል ሕማም ዘምፅእ ኮሮናቫይረስ (SARS-CoV፣SARS-CoV-2)፣ ታይሎኒክተሪስ ባት ኮሮናቫይረስ HKU4፣ናይ ማእኸላይ ምዕራብ ናይ መተንፈሲ ኣካል ሲንድሮም ዘምፅእ ኮሮና ቫይረስ፣ሄጅሆግ ኮሮናቫይረስ 1 (EriCoV)
Species: Beluga whale coronavirus SW1, Infectious bronchitis virus
ዓሌታት: ቤሉጋ ዓሳ ነባሪ ኮሮናቫይረስ SW1፣ ተላባዒ ብሮንካይተስ ፋይረስ
The most recent common ancestor (MRCA) of all coronaviruses is estimated to have existed as recently as 8000 BCE, although some models place the common ancestor as far back as 55 million years or more, implying long term coevolution with bat and avian species.
ዋላ እኳ ገለ ሞዴላት ንሓባራዊ ኣበው ክሳብ ቅድሚ 55 ሚሊዮን ዓመታት እንተቐመጥዎ፡ ካብ ኩሎም ኮሮና ቫይረሳት ኣብ ቀረባ ግዜ ዝፈረየ ኣበው ክሳብ 8000 ቅድሚ ልደተ ክርስቶስ ኣብ ቀረባ እዋን ከምዝነበረ ይግመት ።እዚ ድማ ናይ ነዊሕ ግዜ ፍልቀት ምስ መንካዕን ዑፋዊ ዓሌታትን የመልክት።
The most recent common ancestor of the alphacoronavirus line has been placed at about 2400 BCE, the betacoronavirus line at 3300 BCE, the gammacoronavirus line at 2800 BCE, and the deltacoronavirus line at about 3000 BCE.
እቲ ዝውቱር ዝኾነ ኣበው ናይ ኣልፋኮሮናቫይረስ መስመር ኣብ ከባቢ 2400 BCE፡ ናይ ቤታኮሮናቫይረስ መስመር ድማ ኣብ 3300 BCE ፣ ናይ ጋማኮሮናቫይረስ መስመር ኣብ 2800 ከምኡ’ውን ናይ ደልታኮሮናቫይረስ መስመር ኣብ ከባቢ 3000 BCE ደረጃ ሒዞም።
The large number of host bat and avian species, and their global range, has enabled extensive evolution and dissemination of coronaviruses.Many human coronavirus have their origin in bats.
መብዛሕቲኦም ናይ መንካዕን ናይ ኣዕዋፍ ዘርኢታትን ዓለምለኻዊ ወሰኖምን ን ኮሮና ቫይረስ ዓብዪ ዝግመታዊ ለውጢ ን ምግፋሕንንክህልዎ ርኡይ ተራ ዝተጻውቱ እዮም. መብዛሕቲኦም ን ደቂ ሰባት ዘጥቅዑ ኮርና ቫይረሳት ካብ መንካዓት ዝብገሱ እዮም።
More recently, alpaca coronavirus and human coronavirus 229E diverged sometime before 1960.
ኣብ ቀረባ ግዜ ቅድሚ 1960 ዓመተ ምህረት ኣልፓካ ኮሮና ቫይረስን ናይ ሰብ ኮሮና ቫይረስ 229ኢ ን ተፈላልዮም።
MERS-CoV emerged in humans from bats through the intermediate host of camels.
MERS-CoV ቫይረስ ካብ መንካዕ ናብ ሰባት ብመንገዲ ኣግማል ተቐልቂሉ።
MERS-CoV, although related to several bat coronavirus species, appears to have diverged from these several centuries ago.
MERS-CoV፣ ምስ ብዙሓት ናይ ለዃኺቶ ኮሮናቫይራሳት ዓሌት ዝተተሓሓዘ እንተኾነ ዋላ፣ ካብዚኦም ግን ቅድሚ ብዙሕ ዓመታት ዝተፈለየ ከምዝኾነ የርኢ።
The most closely related bat coronavirus and SARS-CoV diverged in 1986.
ዝቐረበ ዝምድና ዘለዎም ናይ መንኪዕ ኮሮናቫይረስን SARS-CoV ን ኣብ 1986 ተፈላልዮም።
A possible path of evolution, of SARS coronavirus and keen bat coronaviruses, suggests that SARS related coronaviruses coevolved in bats for a long time.
ናይ ዘገምታዊ ለውጢ መንገዲ ክኸውን ይኽእል፣ ን SARS ኮሮናቫይረስን ናይ ለዃኺቶ ኮሮናቫይረስን፣ ምስ SARS ዝተተሓሓዘ ኮሮናቫይረስ ንነዊሕ ግዘ ምስ ለዃኺቶታት ክጸንሕ ክኢሉ እዩ።
In the 1790s, equine coronavirus diverged from the bovine coronavirus after a cross-species jump.
ኣብ 1790 ታት፣ ኢኪዩን ኮሮናቫይረስ ካብ ናይ ከፍቲ ኮሮናቫይረስ ድሕሪ ካብ ዓሌት ናብ ዓሌት ምዝላል ተመሓላሊፉ።
Later in the 1890s, human coronavirus OC43 diverged from bovine coronavirus after another cross-species spillover event.
ካብ ሓደ ዓሌት ናብ ካልእ ዓሌት ዝተገብረ ምትሕልላፍ ምኽንያት ኣብ መወዳእታ 1890ታት ካብ ንኸፍቲ ዘጥቅዕ ኮሮና ቫይረስ ንወድሰብ ዘጥቅዕ ኮሮና ቫይረስ OC43 ተፈጢሩ።
It is speculated that the flu pandemic of 1890 may have been caused by this spillover event, and not by the influenza virus, because of the related timing, neurological symptoms, and unknown causative agent of the pandemic.
እቲ ኣብ 1890 ዝተኸስተ ናይ ፍሉ ለበዳ ብኢንፍሉዌንዛ ቫይረስ ዘይኮነስ በዚ ናይ ምፍሳስ ኣጋጣሚ ከምዝመጸ ተባሂሉ ይግመት። ከምኡ መበሊ ምኽንያት ድማ ናይ ግዜ ኣጋጣሚ , ናይ መትንታት ቃንዛ ምልክታት ከምኡ’ውን መንነቱ ዘይተፈልጠ ጠንቂ ናይቲ ለበዳ እዩ።
Human coronavirus OC43 besides causing respiratory infections is also suspected of playing a role in neurological diseases.
ናይ ሰባት ኮሮናቫይረስ OC43 ናይ ስርዓተ ምትንፋስ ረኽሲታት ምስ ምምጽኡ ጎኒ ንጎኒ ኣብ ናይ ኒሮሎጂካል ሕማማት እውን ዓብዪ ግደ ይጻወት ኣሎ ተባሂሉ ይጥርጠር።
In the 1950s, the human coronavirus OC43 began to diverge into its present genotypes.
ኣብ 1950ታት ንሰብ ዘጥቅዕ ኮሮና ቫይረስ OC43 ናብ’ዚ ሕጂ ዘሎ ዕይነተ-ሰረት ክፍለ ጀሚሩ ።
Phylogentically, mouse hepatitis virus (Murine coronavirus), which infects the mouse's liver and the central nervous system, is related to human coronavirus OC43 and bovine coronavirus.
ፋይሎጀነቲካዊ፣ ናይ ኣንጨዋ ሄፓታይተስ ቫይረስ (ሙሪን ኮሮናቫይረስ)፣ ናይ ኣንጭዋ ጉበትን ማእኸላይ ነርቨስ ስርዓተን የጥቅዕ፣ ምስ ናይ ሰባት ኮሮናቫይረስ OC43 ምስ ናይ ከፍቲ ኮሮናቫይረስን ድማ ተመሳሳሊ እዩ።
Human coronavirus HKU1, like the aforementioned viruses, also has its origins in rodents.
ን ወዲ ሰብ ዘጥቅዕ ኮሮና ቫይረስ HKU1 ቕድሚ እዚ ከምዘተጥቕሱ ሕማማት መበቆሉ ኣብ ኣናፁ እዩ።
Coronaviruses vary significantly in risk factor.
ኮሮናቫይረሳት ብሰፊሑ ኣብ ናይ መምጽኢ ምኽንያታት ዝፈላለዩ እዮም።
Some can kill more than 30% of those infected, such as MERS-CoV, and some are relatively harmless, such as the common cold.
ገሊኦም ከም MERS-CoVስ ዝኣመሰሉ ንልዕሊ 30% ካብዞም ዝተለኽፉ ክቐትሉ ይኽእሉ፡ ገሊኦም ከም ጉንፋዕ ዝመሰሉ ድማ ብተዛማዲ ዘይጓድኡ እዮም።
Coronaviruses can cause colds with major symptoms, such as fever, and a sore throat from swollen adenoids.
ኮሮናቫይረሳት ብቐንዱ ከም ረስኒን ምቑሳል ጎሮሮ ካብ ምሕባጥ ስነ-መዛርዕ ዝርከብዎም ዓበይቲ ምልክታት ዘለዎም ጉንፋዕ ከስዕብ ይኽእል።
Coronaviruses can cause pneumonia (either direct viral pneumonia or secondary bacterial pneumonia) and bronchitis (either direct viral bronchitis or secondary bacterial bronchitis).
ኮሮናቫይረስ ናይ ሳንቡእ ወቕዒ(ወይ ቀጥታዊ ብ ቫይረስ ዝመጽእ ሳንቡእ ወቕዒ ወይ ካልኣይ ደረጃ ናይ ባክቴርያ ሳንቡእ ወቕዒ) ብሮንካይትስን (ወይ ቀጥታዊ ብ ቫይረስ ዝመጽእ ብሮንካይትስ ወይ ካልኣይ ደረጃ ብ ባክተሪያ ዝመጽእ ብሮንካይትስ) ከስዕብ ይኽእል እዩ።
The human coronavirus discovered in 2003, SARS-CoV, which causes severe acute respiratory syndrome (SARS), has a unique pathogenesis because it causes both upper and lower respiratory tract infections.Six species of human coronaviruses are known, with one species subdivided into two different strains, making seven strains of human coronaviruses altogether.
SARS-CoV ዝተብሃለ ኣብ 2003 ዝተረኽበ ንወዲሰብ ዘጥቅዕ ኮሮናቫይረስ ከቢድ ሃንደበታዊ ዝኾነ ናይ ስርዓተ ምትንፋስ ሕማም(SARS) ዘምፅእ እንትኸዉን ላዕለዋይን ታሕተዋይን ስርዓተ ምትንፋስ ስለዘጥቅዕ ድማ ካብ ካልኦት ፍልይ ዘብሎ ኣመጻጽኣን ምዕባለን ኣለዎ። ወዲሰብ ዘጥቅዕ ኮሮናቫይረስ ሽዱሽተ ዘርእታት ኣለዎ። ካብኣቶም እቲ ሓደ ናብ ክልተ ስትሬናት ስለዝምቀል ሸውዓተ ናይ ኮሮናቫይረስ ስትሬናት ይርከቡ።
Four of these coronaviruses continually circulate in the human population and produce the generally mild symptoms of the common cold in adults and children worldwide: -OC43, -HKU1, HCoV-229E, -NL63.
ምስ እዚኣቶም ውሽጢ ኣርባዕተ ኩሉጊዜ ብ ናይ ወድ ሰብ ቍጽሪ ከምኡውን ኣጠቓላሊ ይፍርዩ ብኣበይቲ ብቆልኡት ኣብ ኣለም ሙሉ ውሽጢ ልሙድ ሰዓል ኣጠቓላሊ ምልክታት: -OC43, -HKU1, HCoV-229E, -NL63.
Coronaviruses cause about 15% of commons colds.
ኮሮናቫይረስ ከባቢ 15% ጉንፋዕ የስዕብ ።
The majority of colds are caused by rhinoviruses.
መብዛሕትኦም ሕማማት ጉንፋዕ ብ ራይኖቫይረሳት ዝመጹ እዮም።
The four mild coronaviruses have a seasonal incidence occurring in the winter months in temperate climates.
እቶም ኣርባዕተ ቅልል ዝበሉ ኮሮና ቫይረሳት ወቕታዊ ክስተት ሃልይዎም ኣብ ሚዛናዊ ኩነታት ኣየር ኣብ ዘለዎ ኣብ ወርሓት ሓጋይ ይኽሰቱ።
There is no preference towards a particular season in tropical climates.
ኣብ ናይ ቆላ ኣየር ኩነታት እትመርጾ ዓይነት ወቕቲ የለን።
Four human coronaviruses produce symptoms that are generally mild:
ኣርባዕተ ንወዲሰብ ዘጥቅዑ ኮሮና ቫይረሳት ብጠቕላላ ፎኪስ ምልክታት ዘርእዩ እዮም፡
The virus was officially named the SARS coronavirus (SARS-CoV).
እቲ ቫይረስ ብስሩዕ SARS ኮሮና ቫይረስ ተባሂሉ ተሰይሙ (SARS-CoV)።
More than 8,000 people were infected, about ten percent of whom died.
ካብ 8000 ንላዕሊ ዝኽኑ ሰባት በቲ ረኽሲ ተታሒዞም እዮም ካብ ኣቶም ድማ ከብቢ ዓሰርተ ሚእታዊ ዝኾኑ ሞይቶም።
In September 2012, a new type of coronavirus was identified, initially called Novel Coronavirus 2012, and now officially named Middle East respiratory syndrome coronavirus (MERS-CoV).
ኣብ ሴፕተምበር 2012 ሓድሽ ናይ ኮሮና ቫይረስ ዓይነት ተረኺቡ። ፈለማ ኖቭል ኮሮና ቫይረስ 2012 ተባሂሉ ዝፍለጥ እንትነብር ሕዚ ድማ ሽሙ ናብ ሚድል ኢስት ሪስፓራቶሪ ሲንድረም ኮሮና ቫይረስ (MERS-CoV) ተቐይሩ።
The World Health Organization issued a global alert soon after.
ዉድብ ጥዕና ዓለም ዓለምለኻዊ መጠንቀቕታ ኣዊጁ።
The WHO update on 28 September 2012 said the virus did not seem to pass easily from person to person.
ብዓለማዊ ውድብ ጥዕና ኣብ ሰፕተምበር28, 2012 ዝወጽአ ሓድሽ ሓበሬታ እቲ ቫይረስ ካብ ሰብ ናብ ሰብ ብቐሊሉ ዝመሓላለፍ ኣይመስልን ኢሉ ።
However, on 12 May 2013, a case of human-to-human transmission in France was confirmed by the French Ministry of Social Affairs and Health.
እንተኾነ ግን፣ ኣብ 12 መይ 2013፣ ኣብ ፈረንሳይ ናይ ካብ ሰብ ናብ ሰብ ምምሕልላፍ ብናይ ፈረንሳይ ማሕበራዊን ጥዕናን ጉዳያት ሚኒስተር ጸብጻብ ተገይሩ እዩ።
In addition, cases of human-to-human transmission were reported by the Ministry of Health in Tunisia.
ብተወሳኺ፣ ካብ ሰብ ናብ ሰብ ናይ ምምሕልላፍ ጉዳያት ለበዳ ብናይ ቱኒዝያ ጥዕና ሚኒስተር ሪፖርተ ተገይሩ።
Two confirmed cases involved people who seemed to have caught the disease from their late father, who became ill after a visit to Qatar and Saudi Arabia.
ክልተ ዝተረጋገጹ ጉዳያት ለበዳ ድማ ነዚ ቫይረስ ካብ ናብ ኳታርን ሳዑዲ ዓረበያን ድሕሪ ምጉዓዙ ሓሚሙ ዝሞተ ኣቦኦም ዝተመሓላለፎም እዮም።
Despite this, it appears the virus had trouble spreading from human to human, as most individuals who are infected do not transmit the virus.
እዚ ከምኡ እንተሎ፣ ብዙሓት ዝተለኸፉ ሰባት ነቲ ቫይረስ ዘየመሓላልፉ ብምዃኖም እዚ ቫይረስ ካብ ሰብ ናብ ሰብ ንምምሐልላፍ ዝጸገሞ ይመስል።
The final name for the virus is Middle East respiratory syndrome coronavirus (MERS-CoV).
ናይ’ቲ ቫይረስ ናይ መወዳእታ ስም ማእከላይ-ምብራቕ ሕማም ስርዓተ ምስትንፋስ ኮሮና ቫይረስ እዩ።
The only U.S. cases (both survived) were recorded in May 2014.In May 2015, an outbreak of MERS-CoV occurred in the Republic of Korea, when a man who had traveled to the Middle East, visited four hospitals in the Seoul area to treat his illness.
እቶም ብሕታዊ ናይ U.S. ጉዳያት ለበዳ እቶም ክልተ ኣብ ሜይ 2014 ዝተመዝገቡ እዮም (ክልቲኦም ሓውዮም)። ኣብ ሜይ 2015 ሓደ ናብ ማእኸላይ ምብራቕ ተጓዒዙ ዝመፀ ሰብ ንኽሕከም ኣብ ሴኦል ኣርባዕተ ሆስፒታላት ብምብፃሑ ናይ MERS-CoV ለበዳ ኣብ ሪፐብሊክ ኦፍ ኮሪያ ከጋጥም ክኢሉ ኔሩ።
This caused one of the largest outbreaks of MERS-CoV outside the Middle East.
እዚ ድማ MERS-CoV ካብ ማእኸላይ ምብራቕ ወጻኢ ብዓብዪኡ ክላባዕ ጌርዎ።
As of December 2019, 2,468 cases of MERS-CoV infection had been confirmed by laboratory tests, 851 of which were fatal, a mortality rate of approximately 34.5%.
ካብ ታሕሳስ 2019 ጀሚሩ 2,468 ናይ MERS-CoV ረኽሲ ዝምልከት ጉዳያት ብ ላብራቶሪ መርመራታት ተረጋጊጹ ኣሎ ።ካብዚኦም 851 ቀተልቲ ኮይኖም 34.5% ናይ ሞት መጠን ኣለዎም።
In December 2019, a pneumonia outbreak was reported in Wuhan, China.
ኣብ ዲሰምበር 2019 ኣብ ዉሃን፡ ቻይና ም’ልባዕ ኒሞንያ ከም ዝነበረ ጸብጻብ ተዋሂቡ ኔሩ።
On 31 December 2019, the outbreak was traced to a novel strain of coronavirus, which was given the interim name 2019-nCoV by the World Health Organization (WHO), later renamed SARS-CoV-2 by the International Committee on Taxonomy of Viruses.
ኣብ 31 ዲሰምበር 2019 እቲ ለበዳ ካብ ሓድሽ ናይ ኮሮና ቫይረስ ስትሬን ከምዝመፀ ተፈሊጡ። እዚ ድማ ዉድብ ጥዕና ዓለም 2019-nCoV ብምባል ሰይምዎ። እንተኾነዉን ብዓለምለኻዊ ዉድብ ናይ ቫይረሳት ታክሶኖሚ እቲ ሽም ናብ SARS-CoV-2 ተቐይሩ እዩ።
Some researchers have suggested the Huanan Seafood Wholesale Market may not be the original source of viral transmission to humans.As of 17 April 2020, there have been at least 153,822 confirmed deaths and more than 2,240,191 confirmed cases in the coronavirus pneumonia pandemic.
ናይ ሁናን መሸጢ ናይ ባሕሪ ምግቢ ናይ እቲ ቫይረስ መበቆል ከምዘይኮነ ሓደሓደ ተመራመርቲ ይገልፁ። 17 ኤፕሪል 2020 ኣብ እዚ ለበዳ ኮሮና ቫይረስ ናይ ሳንባ ወቕዒ ለበዳ ብ ንኡሱ153,822 ዝተረጋገፁ ሞትን ልዕሊ 2,240,191 ዝተረጋገፁ ጉዳያት ለበዳን ከምዘለዉ ይንገር።
The Wuhan strain has been identified as a new strain of Betacoronavirus from group 2B with approximately 70% genetic similarity to the SARS-CoV.
ናይ ዉሃን ዘርኢ ብገምጋማዊ 70% ስነ-ሰረታዊ ምምስሳል ምስ SARS-CoV ከም ሓድሽ ዘርኢ ናይ ቤታኮሮና ቫይረስ ካብ ጉጅለ 2ቢ ተለልዩ ኣሎ።
The virus has a 96% similarity to a bat coronavirus, so it is widely suspected to originate from bats as well.
እቲ ቫይረስ ምስ ናይ መንካዕ ኮሮናቫይረስ 96% ምምስሳል ኣለዎ ።ስለ’ዚ ካብ መንካዕ መጺኡ ክኸውን ከም ዝኽእል ብዙሕ ግምታት ኣሎ።
The pandemic has resulted in travel restrictions and nationwide lockdowns in several countries.
እቲ ለበዳ ኣብ ብዙሓት ሃገራት ናይ ጉዕዞ እገዳታትን በ ደረጃ ሃገር ምዕጻዋት ኣስዒቡ እዩ።
Coronaviruses have been recognized as causing pathological conditions in veterinary medicine since the 1930s.
ካብ 1930ታት ጀሚሩ ኮሮና ቫይረስ ኣብ ስነ እንስሳት ሕክምና ፓቶሎጂካል ፀገም ከምዘምፅእ ተፈሊጡ።
Except for avian infectious bronchitis, the major related diseases have mainly an intestinal location.
ካብ ናይ ኣዕዋፍ ተሓላላፊ ናይ መተንፈሲ ሕማማት ወጻኢ ዋና ተቐራራቢ ሕማማት ብዝበልጽ ኣብ መዓናጡ ከባቢ እዩ ቦትኦም።
Coronaviruses primarily infect the upper respiratory and gastrointestinal tract of mammals and birds.
ኮሮና ቫይረስ ብመጀመርታ ደረጃ ናይ መጥበውቲ እንስሳትን ኣዕዋፍን ላዕለዋይ ናይ መተንፈሲ ኣካልን ጋስትሮኢንተስታይናል ትራክትን የጥቅዕ።
They also cause a range of diseases in farm animals and domesticated pets, some of which can be serious and are a threat to the farming industry.
ኣብ ናይ ሕርሻ እንስሳትን ኣብ ገዛ ዝነብሩ ውይድማ ዝለመዱ እንሰሳትን ውሽጢ ብዙሓት ሕማማት ዘስዕቡ እንትኾኑ ካቦኦም ገሊኦም ኣዝዮም ጥንኩራትን ነቲ ናይ ሕርሻ ኢንዱስትሪ ድማ ሓደጋ ክኾኑ ዝኽእሉ እዮም።
In chickens, the infectious bronchitis virus (IBV), a coronavirus, targets not only the respiratory tract but also the urogenital tract.
ኣብ ደርሁ ዝርከብ ተመሓላላፊ ረኽሲ ዝፈጥር ብሮንካይተስ ቫይረስ(IBV)፣ ኮሮና ቫይረስ ተባሂሉ ዝጽዋዕ ክንሱ ናይ መተንፈሲ ኣካል ጥራይ ዘይኮነ እንኮላይ ንኩላሊትን ፍሕኛን ከምኡ’ውን ንካልኦት ኣካላት ሽንቲ ዘጥቅዕ እዩ።
The virus can spread to different organs throughout the chicken.
እቲ ቫይረስ ኣብ’ቲ ደርሆ ናብ ዝተፈላለዩ ክፋላት ከሳፍሕ ይኽእል ።
Economically significant coronaviruses of farm animals include porcine coronavirus (transmissible gastroenteritis coronavirus, TGE) and bovine coronavirus, which both result in diarrhea in young animals.
ኢኮኖሚያዊ ጽልዋኦም ዓብዪ ዝኾኑ ናይ ሕርሻ እንስሳት ኮሮናናቫይረሳት ናይ ሓሰማ ኮሮናቫይረስ (ናይ ጂኦኢንተራይተስ ተመሓላላፊ ኮሮናቫይረስ፣ TGE) ናይ ከፍቲ ኮሮናቫይረስ፣ ክልቲኦም ኣብ መናእሰይ እንስሳት ተቕማጥ የስዕቡ እዮም።
Feline coronavirus: two forms, feline enteric coronavirus is a pathogen of minor clinical significance, but spontaneous mutation of this virus can result in feline infectious peritonitis (FIP), a disease associated with high mortality.
ናይ ድሙ ኮሮና ቫይረስ፡ ክልተ መልክዓት ኣለዎ ።ናይ መዓናጡ ድሙኣዊ ኮሮና ቫይረስ ትሑት ሕክምናዊ ኣገዳስነት ዘለዎ ሰብ ሕማም ክኸውን ከሎ፡ ቀጻሊ ልውጠት ናይ’ዚ ቫይረስ ግን ድሙኣዊ ነድሪ ቋንጡጥ ዝበሃል ብዙሕ ሞት ከስዕብ ዝኽእል ሕማም የስዕብ።
Similarly, there are two types of coronavirus that infect ferrets: Ferret enteric coronavirus causes a gastrointestinal syndrome known as epizootic catarrhal enteritis (ECE), and a more lethal systemic version of the virus (like FIP in cats) known as ferret systemic coronavirus (FSC).
ብተመሳሳሊ ንፌረት ዘጥቅዑ ክልተ ዓይነት ኮሮና ቫይረስ ኣለዉ። ፌረት ኢንተሪክ ኮሮና ቫይረስ ኤፒዙቲክ ካታራል ኢንተራይተስ (ECE) ዝበሃል ጋስትሮኢንተስታይናል ሲንድሮም የምፅእ። ከምኡዉን ፌረት ሲስተሚክ ኮሮና ቫይረስ (FSC) ተባሂሉ ዝፅዋዕ (ኣብ ደማሙ FIP) ዝበሃል ሓደገኛ ሕማም ከምዘምፅእ ይፍለጥ።
There are two types of canine coronavirus (CCoV), one that causes mild gastrointestinal disease and one that has been found to cause respiratory disease.
ክልተ ዓይነታት ክኒን ኮሮና ቫይረሳት ኣለዉ (CCoV)፣ ሓዲኡ ቀሊል ናይ ጋስትሮኢንተስታይናል ሕማም የስዕብ ሓዲኡ ድማ ናይ ምስትንፋስ ሕማም ዘስዕብ እዩ።
Mouse hepatitis virus (MHV) is a coronavirus that causes an epidemic murine illness with high mortality, especially among colonies of laboratory mice.
ናይ ኣናጹ ሄፒታይተስ ቫይረስ (MHV) ናይ ኮሮና ቫይረስ ዓይነት ኮይኑ ብፍላይ ድማ ንናይ ቤት-ፈተነ ኣናጹ ቀታሊ ለበዳን ዓቢ ናይ ሞት መጠን ዘለዎን ሕማም እዩ።
Sialodacryoadenitis virus (SDAV) is highly infectious coronavirus of laboratory rats, which can be transmitted between individuals by direct contact and indirectly by aerosol.
ሲያሎዳክሪዮኣደናይቲስ ቫይረስ(SDAV) ኣዝዩ ተላጋቢ ናይ ላብራቶሪ ኣናጹ ኮሮና ቫይረስ ኮይኑ መንገዲ ቀጥታዊ ርክባትን ብዘይቀጥታዊ ኣየሮሶልን ኣብ ሞንጎ ውልቀሰባት ክመሓላለፍ ይኽእል ።
Some strains of MHV cause a progressive demyelinating encephalitis in mice which has been used as a murine model for multiple sclerosis.
ገለ ዘርኢ ናይ MHV ኣብ ኣናጹ ቀጻሊ ነድሪ ሓንጎል ከስዕቡ ይኽእሉ ።እዚ ድማ ከም ሞደል ኣናጹ ን ሕማም ስርዓተ-መትኒ ክጠቀሙሉ ጸኒሖም ።
Significant research efforts have been focused on elucidating the viral pathogenesis of these animal coronaviruses, especially by virologists interested in veterinary and zoonotic diseases.
ብሉጻት ናይ መጽናዕቲ ጻዕሪታት ናይ እዞም ናይ እንስሳት ኮሮናቫይረሳት ቫይራል ፓቶጀነሲስ ኣብ ምብርህራህ ኣተኲሮም ጸኒሖም፣ ብፍላይ ድማ በቶም ኣብ ቨተርነሪን ናይ እንስሳት ሕማማትን ቫይሮሎጂ ድሌት ዘለዎም ሰባት።
Porcine coronavirus (transmissible gastroenteritis coronavirus of pigs, TGEV).
ፖርሲን ኮሮና ቫይረስ (ናይ ሓሰማ ኮርና ቫይረስ ተመሓላላፊ ጋስትሮኢንተራይተስ፣ TGEV)።
Bovine coronavirus (BCV), responsible for severe profuse enteritis in of young calves.
ቦቫይን ኮሮና ቫይረስ(BCV) ኣብ ነኣሽቱ ምራኹት ከቢድ ነድሪ-መዓናጡ ጠንቂ እዩ።
Feline coronavirus (FCoV) causes mild enteritis in cats as well as severe Feline infectious peritonitis (other variants of the same virus).
ድሙኣዊ ኮሮና ቫይረስ(FCoV) ኣብ ደማሙ ፈኲስ ነድሪ-መዓናጡን ከቢድ ተላባዒ ነድሪ-ቋንጡጥን(ካልእ ዝዓይነቶም ናይ’ቲ ቫይረስ ባዕሉ) የስዕብ።
the two types of canine coronavirus (CCoV) (one causing enteritis, the other found in respiratory diseases).
እቶም ክልተ ዓይነታት ከይናይን ኮሮና ቫይረስ (CCoV) (እቲ ሓደ ረኽሲ መዓናጡ ዘምፅእ እንትኸዉን እቲ ካልኣይ ድማ ስርዓተ ምትንፋስ ዘጥቅዕ እዩ)።
Turkey coronavirus (TCV) causes enteritis in turkeys.
ቱርኪ ኮሮና ቫይረስ (TCV) ኣብ ቆቓሓት ኢንተራይተስ የምፅእ።
Ferret enteric coronavirus causes epizootic catarrhal enteritis in ferrets.
ናይ ፌሬት ኢንተሪክ ኮሮናቫይረስ ኣብ ፌሬታት ኢፒዙቲክ ካቴተራል ኢንተራይቲስ ይፈጥር።
Ferret systemic coronavirus causes FIP-like systemic syndrome in ferrets.
ናይ ፋሬቶ ኣካላዊ ኮሮና ቫይረስ ን FIP - ዝመስል ኣካላዊ ምልክታት ሕማም ኣብ ፋሬቶ የስዕብ።
Rabbit enteric coronavirus causes acute gastrointestinal disease and diarrhea in young European rabbits.
ራቢት እንተሪክ ኮሮናቫይረስ ከቢድ ናይ መዓናጡ ሕማማን ተቕማጥን ኣብ ናይ ኣውሮፓ ማንቲለታት የብፅሕ።
Porcine epidemic diarrhea virus (PED or PEDV), has emerged around the world.
ተላባዒ ውጽኣት ፖርሲን ቫይረስ (PED ወይ PEDV) ኣብ ዓለም ተቐልቂሉ ኣሎ ።
b'Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
ሕማም b'ኮሮናቫይረስ 2019 (ኮቪድ-19) ብከቢድን ህጹጽ ናይ ስርዓተ ምስትንፋስ ሲንድረም ኮሮናቫይረስ 2 (SARS-CoV-2) ዝመጽእ ተላባዒ ሕማም እዩ።
Common symptoms include fever, cough, and shortness of breath.
ልሙዳት ምልክታት ረስኒ፣ ሰዓልን ትንፋስ ምሕጻርን ዝኣመሰሉ ዘካትቱ እዮም።
Other symptoms may include fatigue, muscle pain, diarrhea, sore throat, loss of smell, and abdominal pain.
ካልኦት ምልክታት ድኻም፣ ናይ ጭዋዳ ቃንዛ፣ ተቕማጥ፣ ናይ ጎሮሮ ቃንዛ፣ ናይ ምጭናው ክእለት ምስኣንን ናይ ከብዲ ቃንዛን የካትቱ።
The time from exposure to onset of symptoms is typically around five days but may range from two to fourteen days.
ካብ ግዘ ምቅላዕ ክሳብ ምልክት ምርኣይ ዝጅምረሉ ግዘ ዘሎ ግዘ ከባቢ ሓሙሽተ መዓልቲታት እዩ፣ እንተኾነ ግን ካብ ክልተ ክሳብ ዓሰርተ ኣርባዕተ መዓልቲታት ኣብ ዘሎ ክፈላለ ይኽእል እዩ።
While the majority of cases result in mild symptoms, some progress to viral pneumonia and multi-organ failure.
መብዛሕትኦም ጉዳያት ናይ ለበዳ ቀለልቲ ምልክታት ዘርእዩ ዋላ እንተኾኑ፣ ገለ ናብ ቫይራል ናይ ሳንቡእ ወቕዒን ናብ ብዙሓት ኦርጋናት ውድቀትን ዘምርሑ እዮም።
As of 17 April 2020, more than 2.24 million cases have been reported across 210 countries and territories, resulting in more than 153,000 deaths.
ካብ 17 ኣፕሪል 2020 ጀሚሩ፣ ልዕሊ 2.24 ሚልዮን ጉድያት ለበዳ ኣብ መላእ 210 ሃገራትን ግዝኣታትን ጸብጻብ ተገይሮም እዮም፣ ልዕሊ 153,000 ሞት ድማ ኣስዒቦም።
More than 568,000 people have recovered.The virus is primarily spread between people during close contact, often via small droplets produced by coughing, sneezing, or talking.
ልዕሊ 568,000 ሰባት ካብቲ ሕማም ሓውዮም እዮም። እዚ ቫይረስ መብዛሕትኡ ግዘ ብምስዓል፣ ብምህንጣስ፣ ወይ ብምዝራብ ዝወጹ ኣናእሽተይ ንጣባት ኣብ መንጎ ቀረባ ንኽክእ ዘለዎም ሰባት እዩ ብዋናነት ዝመሓላለፍ ።
While these droplets are produced when breathing out, they usually fall to the ground or onto surfaces rather than being infectious over long distances.
እዞም ንጣባት ንደገ ኣብ ምትንፋስ ዝፍጠሩ ዋላ እንተኾኑ፣ ናብ ነዊሕ ርሐቐት ከይዶም ክንዲ ሰብ ምብካል ናብ መሬት ወይ ካልኦት ቦታታት እዮም ዝወድቁ።
People may also become infected by touching a contaminated surface and then touching their eyes, nose, or mouth.
ሰባት ዝተበከለ ቦታ ነኺኦም ዓይኖም፣ ኣፍንጭኦም ወይ ኣፎም ብምንካእ ክልከፉ ይኽእሉ እዮም።
The virus can survive on surfaces up to 72 hours.
እዚ ቫይረሳት ኣብ ደጋዊ ቦታታት ን 72 ሰዓታት ዝኣክል ክጸንሕ ይኽእል እዩ።
It is most contagious during the first three days after the onset of symptoms, although spread may be possible before symptoms appear and in later stages of the disease.The standard method of diagnosis is by real-time reverse transcription polymerase chain reaction (rRT-PCR) from a nasopharyngeal swab.
ኣብ ናይቲ ምልክታት ዝጀመረሉ ናይ መጀመርያ ሰለስተ መዓልቲታት ኣዝዩ ተመሓላላፊ እዩ፣ ምምሕልላፍ ኣብ ዳሕራይ ናይቲ ሕማ ደረጃታት እውን ክፍጠር ዝኽእል እንተኾነ እውን። ናይ ሕማም ውጽኢት ምርካብ ስታንዳርድ ሜላ ብናይ ብሓቂ ሪቨርስ ትራንስክሪፕቴዝ ፖሊመሬዝ ቸይን (rRT-PCR) ካብ ናዞፋሬንጃል ስዋብ ብምውሳድ እዩ።
The use of masks is recommended for those who suspect they have the virus and their caregivers.
ማስክ ምጥቃም ነቶም ባዕሎምን ሓብሐብቶምን በቲ ቫይረስ ተታሒዝና ኢና ኢሎም ዝጥርጥሩ እዩ ዝምከር።
Recommendations for mask use by the general public vary, with some authorities recommending against their use, some recommending their use, and others requiring their use.
እቲ ሓፈሻዊ ህዝቢ ማስክ ናይ ምጥቃም ምኽሪ ዝተፈላለየ እዩ፣ ገለ ሰበ ስልጣናት ክጥቀም የብሉን ይብሉ፣ ገለ ክጥቀም ይመኽሩ፣ ካልኦት ድማ ጠቓሚነቶም ይደልዩ።
Currently, there is no vaccine or specific antiviral treatment for COVID-19.
ኣብዚ ግዘ እዚ፣ ንኮቪድ-19 ንጹር ጸረ ቫይረስ መድሓኒት ወይ ክትባት የለን።
Local transmission of the disease has been recorded in most countries across all six WHO regions.
ከባቢያዊ ናይ እቲ ሕማም ስርጭት ኣብ መላእ ኩሎም ሽድሽተ ናይ WHO ክልላት ተመዝጊቡ ኣሎ።
Those infected with the virus may be asymptomatic or develop flu-like symptoms such as fever, cough, fatigue, and shortness of breath.
በዚ ቫይረስ ዝተጠቕዑ ሰባት ምልክት ዘይከርእዩ ይኽእሉ ወይ ድማ ከም ረስኒ፣ ሰዓል፣ ድኻምን ትንፋስ ምሕጻርን ዝኣምሰሉ ናይ ጉንፋዕ ምልክታት ጥራሕ ከማዕብሉ ይኽእሉ እዮም።
Emergency symptoms include difficulty breathing, persistent chest pain or pressure, confusion, difficulty waking, and bluish face or lips; immediate medical attention is advised if these symptoms are present.
ከም ናይ ምስትንፋስ ምሕጻር፣ ቀጻላይ ናይ ኣፍ ልቢ ቃንዛ፣ ምድንጋር፣ ናይ ምስጓም ጸገም፣ ሰመያዊ ገጽ ወይ ከንፈር ዝበሉ ሃንደበታዊ ምልክታት እንተተራእዮም ብቕልጡፍ ናይ ሕክምና ትኹረት የድልዮም እዩ።
Less commonly, upper respiratory symptoms such as sneezing, runny nose or sore throat may be seen.
ክንድቲ ዘይተለመዱ፣ ናይ ላዕለዋይ መተንፈሲ ኣካል ምልክታት ከም ምህንጣስ፣ ኣፍንጫ ዘረብረብ ምባል ወይ ናይ ጎሮሮ ቃንዛ ክጠቓለሉ ይኽእሉ እዮም።
Gastrointestinal symptoms such as nausea, vomiting and diarrhoea have been observed in varying percentages.
ከም ምቕልውላው፣ ቮሚትን ተቕማጠን ዝበሉ ጋስትሮኢንተስታይናል ምልክታት ብ ዝተፈላለዩ ምኢታዊ መጠናት ተራእዮም ኔሮም እዮም።
Some cases in China initially presented only with chest tightness and palpitations.
ገለ ናይ ቻይና ጉዳያት ለበዳ ኣብ መጀመርያ ናይ ኣፍ ልቢ ጸቕጢን ፓልፕቴሽንን ምልክታት ጥራሕ እዮም ኔሮምዎም።
In some, the disease may progress to pneumonia, multi-organ failure, and death.
ኣብ ገለ ሰባት፣ እቲ ሕማም ናብ ናይ ሳንቡእ ወቕዒ፣ ናብ ናይ ብዙሓ ኣካላት ውድቀት ከምኡውን ናብ ሞት ይኽእል።
This is called the incubation period.
እዚ ድማ መራብሒ ግዘ ይበሃል።
The incubation period for COVID-19 is typically five to six days but may range from two to 14 days.
ናይ ኮቪድ -19 መጫጭሒ ግዘ ካብ ሓሙሽተ ክሳብ ሽዱሽተ መዓልቲ ዘሎ ግዘ እዩ እንተኾነ ግን ካብ ክልተ ክሳብ 14 መዓልቲታት እውን ክወስድ ይኽእል እዩ።
97.5% of people who develop symptoms will do so within 11.5 days of infection.Reports indicate that not all who are infected develop symptoms.
97.5% ምልክታት ዘማዕብሉ ሰባት ኣብ ውሽጢ ናይ እቲ ረኸሲ 11.5 መዓልቲታት የርእዩ። ጸብጸባት ከምዘርአይዎ ኩሎም ዝተለኸፉ ምልክት የርእዩ ማለት ኣይኮነን።
The role of these asymptomatic carriers in transmission is not yet fully known; however, preliminary evidence suggests that they may contribute to the spread of the disease.
ናይ እዞም ምልክት ዘየርእዩ ተሸከምቲ መመሓላለፊ መንገዲ ክሳብ ሕዚ ሙሉእ ብሙሉአ ኣይተፈልጠን; እነተኾነ ግን፣ ናይ መጀመርታ መረዳእታት ነቲ ናየ ቫይረስ ዝርጋሐ ክሕግዙ ይኽእሉ እዮም ዝብል ኣንፈት ይህቡ።
The proportion of infected people who do not display symptoms is currently unknown and being studied, with the Korea Centers for Disease Control and Prevention (KCDC) reporting that 20% of all confirmed cases remained asymptomatic during their hospital stay.
ምልክት ናይ ዘየርእዩ ዝተለኸፉ ሰባት በዝሒ ኣብዚ ግዘ እዚ ኣይፍለጥን፣ ጽንዓት ድማ ይግበረሉ ኣሎ፣ ምስ ናይ Korea Centers for Disease Control and Prevention (KCDC) ( ኮርያ ናይ ሕማም ቁጽጽርን ምክልኻልን ማእኸል ) 20% እቶም ዝተረጋገጹ ጉዳይት ለበዳ ኣብ ናይ ሆስፒታል ጻንሒቶም ምልክት ኣይርአዩን ክብል ጸብጻብ ጌሩ።
China's National Health Commission began including asymptomatic cases in its daily cases on 1 April; of the 166 infections on that day, 130 (78%) were asymptomatic at the time of testing.
ናይ China's National Health Commission( ቻይና ብሄራዊ ጥዕና ኮሚሽን) ኣብ 1 ኣፕሪል ምልክት ዘየርእዩ ጉድያት ለበዳ ከጠቓልል ጀሚሩ; ካብ 166 ኣብ እቲ መዓልቲ ዝተመዝገቡ ጉዳያት ለበዳ፣ 130 (78%) ምልክት ዘየርእዩ ኔሮም ክምርመሩ ከለዉ።
Both sputum and saliva can carry large viral loads.
ዓኽታን ትፈታፍን ብዙሕ ናይ ቫይረስ በዝሒ ክሕዙ ይኽእሉ እዮም።
Loud talking releases more droplets than normal talking.
ዓዊ ኢልካ ምዝራብ ካብ ልሙድ ኣዘራርባ ንላዕሊ ብዙሓት ንጣባት ይሰድድ።
A study in Singapore found that an uncovered cough can lead to droplets travelling up to 4.5 meters (15 feet).
ኣብ ሲንጋፖር ዝተኻየደ መጽናዕቲ ኣፍካ ከይሸፈንካ ምስዓል ንጣባት ክሳብ 4.5 ሜትር (15 ፊት) ክጎዓዙ ክገብር ከምዝኽእል ኣርእዩ።
Though the virus is not generally airborne, the National Academy of Science has suggested that bioaerosol transmission may be possible and air collectors positioned in the hallway outside of people's rooms yielded samples positive for viral RNA.
እዚ ቫይረስ እዚ ሙሉእ ብሙሉእ ብኣየር ዝመሓላለፍ ሕማም ስለዘይኮነ፣ በሄራዊ ናይ ሳይንስ ኣካዳሚ ናይ ባዮኤሮሶል ምምሕልላፋት ክህሉ ይኽእል ኣየር ኣከብቲ ድማ ኣብ ናይ ካልኦት ሰባት ክፍሊ ዝርከቡ ሰባት ናሙና ንናይቲ RNA ፖዚቲቭ ውጽኢት ኣርእዩ።
Some medical procedures such as intubation and cardiopulmonary resuscitation (CPR) may cause respiratory secretions to be aerosolised and thus result in airborne spread.
ገለ ናይ ሕክምና ከይዲታት ከም ኢንቱቤሽነንን ካርድዮፕሉምናሪ ሪሰስቴሽን (CPR) ኤሮላይዝድ ክኾኑ ዘለዎም ናይ መተንፈሲ ፈሰስቲ ከስዕቡ ይኽእሉ እዚ ድማ ብኣየር ምምሐልላፍ ከስዕብ ይኽእል።
While there are concerns it may spread via feces, this risk is believed to be low.The virus is most contagious when people are symptomatic; while spread may be possible before symptoms emerge, the risk is low.
ብሰገራ ክመሓላለፍ ይኽእል እዩ ዝብል ስግኣት ዋላ እንተሃለወ፣ እዚ ኣጋጣሚ እዚ ትሑት እዩ ተባሂሉ ይእመን። እዚ ቫይረስ እቶም ሰባት ምልክት የርእዩ እንተልዮም እዩ ብዝበለጸ ዝላባዕ፣ እንቶኾነ ግን ዝርጋሐ ቅድሚ ምልክታት ምፍጣሮም እውን ክፍጠር ይኽእል እዩ፣ ኣጋጣሚኡ ግን ትሑት እዩ።
The European Centre for Disease Prevention and Control (ECDC) says while it is not entirely clear how easily the disease spreads, one person generally infects two to three others.The virus survives for hours to days on surfaces.
ናይ European Centre for Disease Prevention and Control (ECDC) (ኣውሮፓ ናይ ሕማም ምክልኻልን ቁጽጽርን ማእኸል) እቲ ሕማም ክንደየናይ ብቐሊሉ ከምዝመሓላለፍ ግልጺ ከምዘይኮነን፣ ሓደ ሰብ ክልተ ወይ ሰልስተ ዝኾኑ ሰባት ክብል ከምዝኽእልን ሓቢሮም። እዚ ቫይረስ ኣብ ዝኾነ ቦታ ንሰዓታት ክጸንሕ ድማ ይኽእል እዩ።
Specifically, the virus was found to be detectable for one day on cardboard, for up to three days on plastic (polypropylene) and stainless steel (AISI 304), and for up to four hours on 99% copper.
ብፍላይ ድማ፣ እቲ ቫየረስ ኣብ ኣርማድዮ ሓደ መዓልቲ ክጸንሕ ክኢሉ እዩ፣ ንሰለስተ መዓልቲታት ድማ ኣብ ፕላስቲክ (polypropylene) ኣብ ስተይንለስ ስቲል እውን (AISI 304)፣ ኣብ 99% ኮፐር ድማ ንኣርባዕተ ሰዓታት ይጸንሕ።
This, however, varies depending on the humidity and temperature.
እዚ ግን፣ በቲ ራሕሲን ሙቐትን መሰረት ክፈላለ ይኽእል እዩ።
Soap and detergent are also effective if correctly used; soap products degrade the virus' fatty protective layer, deactivating it, as well as freeing them from skin and other surfaces.
ሳሙናን ዲተርጀንትን እውን ብኣግባቡ ኣብ ጥቕሚ እንተውዒሎም ብቑዓት እዮም፣ ናይ ሳሙና ምህርቲታት ናይ እቲ ቫይረስ መከላኸሊ መሸፈኒ ኣካል የዳኽሙ፣ ከይሰርሕ ድማ ይገብርዎ፣ ካብ ቆርበትን ካብ ካልኦት ቦታታት ድማ የጽርይዎ።
Other solutions, such as benzalkonium chloride and chlorhexidine gluconate (a surgical disinfectant), are less effective.In a Hong Kong study, saliva samples were taken a median of two days after the start of hospitalization.
ካልኦት ፈሰስቲ፣ ከም benzalkonium chloride ን chlorhexidine gluconate (ሰርጂካል ዲስኢንፌክታንት)፣ ትሕት ዝበለ ኣድማዒነት ኣለዎም። ኣብ ሆንግ ኮንግ ብዝተገበረ መጽናዕቲ፣ ድሕሪ ኣብ ሆስፒታል ደቂስካ ምሕካ ምጅማሩ ናይ እንትፍታፍ ናሙናታት ብማእኸላይ ኣብ ክልተ መዓልቲታት ተወሲዶም።
In five of six patients, the first sample showed the highest viral load, and the sixth patient showed the highest viral load on the second day tested.
ካብ ሽዱሽተ ተሓከምቲ ሓሙሽቲኦም፣ አቲ ናይ መጀመርያ ናሙና እቲ ዝለዓለ ናይ ቫይረስ በዝሒ ኣርእዩ፣ እቲ ሻዱሻይ ድማ ኣብ ካልኣይ መዓልቱ ክምርመር እንከሎ ዝለዓለ ናይ ቫይረስ በዝሒ ኣርእዩ።
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel severe acute respiratory syndrome coronavirus, first isolated from three people with pneumonia connected to the cluster of acute respiratory illness cases in Wuhan.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ንመጀመርታ ኣብ ከተማ ዉሃን ሰለስተ ከቢድ ናይ ምትንፋስ ሕማምን ናይ ሳምባ ምቺ ሕማም ኣብዝተረኽቦም ሰለስተ ሰባት ተራእዩ።
All features of the novel SARS-CoV-2 virus occur in related coronaviruses in nature.
ናይ እዚ ሓድሽ SARS-CoV-2 ቫይረስ ኩሎም ባህርያታት ብተፈጥሮኦም ምስ ኮሮናቫይረስ ዝመሳሰሉ ኮይኖም እዮም ዝርከቡ።
Outside the human body, the virus is killed by household soap, which bursts its protective bubble.SARS-CoV-2 is closely related to the original SARS-CoV.
ካብ ናይ ሰብ ሰብነት ወጻኢ፣ እዚ ቫይረስ በቲ ናይ ዳጋዊ መከላኸሊኡ ዘንተዓሉ፣ ናይ ገዛ ሳሙና ይመውት እዩ፣ SARS-CoV-2 ምስ እቲ ዋና SARS-CoV ተመሳሳሊ እዩ።
The lungs are the organs most affected by COVID-19 because the virus accesses host cells via the enzyme angiotensin-converting enzyme 2 (ACE2), which is most abundant in the type II alveolar cells of the lungs.
ሳንቡእት እዮም ብኮቪድ-19 ብ ኣብዝሓ ዝጉድኡ ኦርጋናት ምኽንያቱ እቲ ቫይረስ ናብ እቲ ናይ እቲ ሰብ ዋህዮታት ብኤንዛይም ኣንጂዮቴንሲን-ቀያሪ ኤንዛይም 2 (ACE2) ብምጥቃም ይኣቱ፣ እዚ ድማ ኣብ ናይ ሳንቡኣት ዓይነት II ኣሊቪዮላር ዋህዮታት ብበዝሒ እዩ ዝርከብ።
The virus uses a special surface glycoprotein called a "spike" (peplomer) to connect to ACE2 and enter the host cell.
እዚ ቫይረስ ፍሉይ ግላይኮፕሮቲን "ስፓይክ" (peplomer) ተጠቒሙ ምስ ACE2 ይተሓሓዝ እሞ ናብ እቲ ናይ እቲ ሰብ ዋህዮ ይኣቱ።
Acute cardiac injury was found in 12% of infected people admitted in hospital in Wuhan, China, and is more frequent in severe disease.
ከቢድ ናይ ልቢ ጉድኣት ኣብ 12% ዝተለኸፉ ሰባት ተረኺቡ ኣብ ውሃን፣ ቻይና ሆስፒታል ኣብ ዝኣተዉ ሕሙማት ኣጋጢሙ፣ ኣብ ኣዝዮም ዝሓመሙ ሰባት ድማ ይብእስ።